COMPARISON OF TOTAL ANTIOXIDANT CAPACITY AND CD-4 IN PATIENTS WITH HIV STAGE I AND STAGE IV

Nirmayanti Jalil (Department of Dermatology and Veneorology, Faculty of Medicine, Hasanuddin University)
A M Adam (Department of Dermatology and Veneorology, Faculty of Medicine, Hasanuddin University)
Khairuddin Djawad (Department of Dermatology and Veneorology, Faculty of Medicine, Hasanuddin University)
Arifin Seweng (Department of Biostatics , Faculty of Community Health, Hasanuddin University)
Risna Halim (Department of Internal Medicine, Faculty of Medicine, Hasanuddin University)
Anni Adriani (Department of Internal Medicine, Faculty of Medicine, Hasanuddin University)

Nusantara Medical Science Journal
Volume 2 No. 1 Januari - Juni 2017

ABSTRACT Introduction: The role of Total Antioxidant Capacity (TAC) is the cumulative effect of all the antioxidants found in the blood and body fluids. Objective: to know the total antioxidant status in patients with HIV and CD4 stage I and stage IV. Methods: Thirty-four patients with HIV who are  divided into two groups, one was HIV patients with stage I and  group  2 was HIV patients with stage IV. Checking of total antioxidant status and CD4 in both groups. Results: There was no significant difference in total antioxidant status in HIV oenderita stage I and stage IV. There are significant differences in the levels of CD4 HIV patients with stage I and stage IV. There  is a relationship between total antioxidant status and CD4 in patients with HIV. Conclusion: the higher the CD4 count,  the higher the total antioxidant capacity in patients with HIV. Keywords : CD4, Patients HIV, Total Antioxidant Capacity